J Korean Thyroid Assoc.  2013 Nov;6(2):135-139. 10.11106/jkta.2013.6.2.135.

Metastatic Hemangiopericytoma of the Thyroid Gland

Affiliations
  • 1Department of Surgery, Chonbuk National University Medical School, Jeonju, Korea. yhj0903@jbnu.ac.kr
  • 2Department of Pathology, Chonbuk National University Medical School, Jeonju, Korea.
  • 3Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, Korea.

Abstract

Hemangiopericytoma (HPC) is a mesenchymal neoplasm constituting a minor portion of vascular tumors. Although HPCs are generally benign, some progress in a malignant course, leading to recurrence and metastasis even after radical surgery. We present a case of metastatic HPC of the thyroid gland, a very rare site of occurrence. Histological findings revealed a single, well-margined mass with high cellularity. Tumor cells were tightly packed spindle-shaped to round cells arranged around numerous thin-walled vessels. Tumor cells showed cytoplasmic immunoreactivity for CD34 and CD99. To our knowledge, this is the eleventh case reported worldwide and the first case in South Korea.

Keyword

Hemangiopericytoma; Thyroid; Metastasis; Solitary fibrous tumor

MeSH Terms

Cytoplasm
Hemangiopericytoma*
Neoplasm Metastasis
Recurrence
Republic of Korea
Solitary Fibrous Tumors
Thyroid Gland*

Figure

  • Fig. 1. Preoperative chest computed tomography. A 3.3X2.6 -cm-sized, well-circumscribed, round mass was observed within the left lobe of the thyroid. The mass showed heterogeneous enhancement on contrast phase. Calcification was not observed, and there was no evidence of adjacent tissue invasion.

  • Fig. 2. Gross findings of the thyroid mass. A 3.6X3.2–cm-sized mass was observed within the left lobe of the thyroid. The mass was yellowish-white in color, relatively soft, and well-defined.

  • Fig. 3. Microscopic findings of the thyroid mass. (A) Low-power view of the thyroid revealed a well–marginated, encapsulated mass with evenly distributed cellularity (H & E, X40). (B) Tumor cells were tightly packed and arranged around numerous thin-walled vessels. The cells were spindle-shaped to round and of uniform size, with small amounts of pale or eosinophilic cytoplasm with indistinct margins (H & E, X200). (C) Tumor cells revealed cytoplasmic immunoreactivity for CD34 (CD34, X200). Delicate, branching vessels were accentuated. (D) Tumor cells revealed cytoplasmic immunoreactivity for CD99 (CD99, X200).


Reference

References

1. Proietti A, Sartori C, Torregrossa L, Vitti P, Aghababyan A, Fregoli L, et al. A case of metastatic haemangiopericytoma to the thyroid gland: Case report and literature review. Oncol Lett. 2012; 3(6):1255–8.
Article
2. Stout AP, Murray MR. Hemangiopericytoma: a vascular tumor featuring Zimmermann's pericytes. Ann Surg. 1942; 116(1):26–33.
Article
3. Goldblum JR, Weiss SW. Soft tissue tumors. New York, NY: Mosby;2008.
4. Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology. 2006; 48(1):63–74.
Article
5. Enzinger FM, Weiss SW. Soft tissue tumors. New York, NY: Mosby;1995.
Article
6. Hansen T, Gaumann A, Ghalibafian M, Hoferlin A, Heintz A, Kirkpatrick CJ. Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease. Virchows Arch. 2004; 445(3):315–9.
Article
7. Espat NJ, Lewis JJ, Leung D, Woodruff JM, Antonescu CR, Shia J, et al. Conventional hemangiopericytoma: modern analysis of outcome. Cancer. 2002; 95(8):1746–51.
8. Enzinger FM, Smith BH. Hemangiopericytoma. An analysis of 106 cases. Hum Pathol. 1976; 7(1):61–82.
9. Spitz FR, Bouvet M, Pisters PW, Pollock RE, Feig BW. Hemangiopericytoma: a 20-year single-institution experience. Ann Surg Oncol. 1998; 5(4):350–5.
Article
10. Schiariti M, Goetz P, El-Maghraby H, Tailor J, Kitchen N. Hemangiopericytoma: long-term outcome revisited. Clinical article. J Neurosurg. 2011; 114(3):747–55.
Full Text Links
  • JKTA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr